While targeting catalase holds promise, there are several challenges. Catalase is also essential for normal cell function, and its inhibition could lead to unintended side effects. Additionally, cancer cells are adept at adapting to therapeutic pressures, and they may develop compensatory mechanisms to overcome catalase inhibition.
